Methyl Nicotinate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
93-60-7
Molecular formula
C7H7NO2
Molecular weight
137.14 g/mol
Drug class
Nicotinic acid estertopical rubefacient and peripheral vasodilator
Mechanism of action
Hydrolyses locally to nicotinic acid, producing prostaglandin-mediated vasodilation and cutaneous erythema. The local increase in skin blood flow produces a warming or rubefacient effect.
Indications / reported uses
Topical rubefacient component in preparations for temporary relief of minor muscular aches and pains and in selected counterirritant products.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Methyl Nicotinate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Methyl Nicotinate Permitted Daily Exposure (PDE) report (the Methyl Nicotinate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Methyl Nicotinate Occupational Exposure Limit (OEL) report (the Methyl Nicotinate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.